Thursday, March 24, 2022

An Interview With Ventavia and Pfizer-BioNTech COVID Vaccine Trial Whistleblower Brook Jackson

Brook Jackson has over 20 years clinical trial managerial experience. She was employed by Ventavia, a Pfizer vaccine trial contractor, in September 2020 as a regional managers during Phase 3 of Pfizer’s COVID-19 vaccine trial. She oversaw three of Ventavia’s trial sites in Texas, covering over 1,000 trial participants.

Jackson claimed Ventavia committed fraud, put patient safety at risk and engaged in cover-ups of errors and malfeasance during its management of Pfizer’s clinical trials.